On the other side, the inhibition of NF-κB activation decreases chemically induced lung carcinogenesis, demonstrating the contribution of NF-κB to carcinogen-induced inflammation and consequent tumor formation [9]. The gene discussed is NFKB1; the disease is neoplasm.